Skip to Content

Tag: Medicare Coverage of Innovative Technology (MCIT)


Also Noted

AdvaMed disagrees with administration on ‘breakthrough’ technology

September 20, 2021HME News Staff

WASHINGTON – AdvaMed says the administration’s decision to fully repeal a final rule on Medicare Coverage of Innovative Technology is “unfortunate.” In a statement, AdvaMed President and CEO Scott Whitaker said the federal government should be providing incentives to access new breakthrough technologies. “Any Medicare patient and their doctor who has exhausted all existing medical options should have immediate access to FDA-approved breakthrough medical technologies,”...

AdvaMed, Medicare Coverage of Innovative Technology (MCIT)


Read Full Articlered right arrow icon

Also Noted

CMS to start over on innovative technology final rule

September 14, 2021HME News Staff

WASHINGTON – CMS has issued a notice of proposed rulemaking that seeks to fully repeal a final rule on Medicare Coverage of Innovative Technology and the definition of “reasonable and necessary.” The rule was published in the Federal Register on Jan. 14, 2021, with an effective date that has been delayed until Dec. 15, 2021. The NPRM will include a public comment period and will detail the agency’s intent to conduct future rulemaking to expediate a coverage pathway for...

Medicare Coverage of Innovative Technology (MCIT)


Read Full Articlered right arrow icon

News

CMS further delays new technology pathway

May 17, 2021HME News Staff

WASHINGTON – CMS in a final rule filed last week further delayed the effective date for a Medicare coverage pathway to provide beneficiaries access to new, innovative medical devices designated as breakthrough technology by the U.S. Food and Drug Administration.  The effective date for Medicare Coverage of Innovative Technology, as well as implementing regulatory standards to be used in making reasonable and necessary determinations under the Social Security...

Medicare Coverage of Innovative Technology (MCIT), Reasonable and Necessary Determinations


Read Full Articlered right arrow icon

News

CMS delays rule outlining new technology pathway 

March 15, 2021HME News Staff

WASHINGTON – CMS has delayed the January effective date of a final rule that established a Medicare coverage pathway to provide beneficiaries access to new, innovative medical devices designated as breakthrough technology by the U.S. Food and Drug Administration.  The agency says it is delaying the final rule’s effective date for 60 days to ensure that the rulemaking process was procedurally adequate; that it properly...

Innovative technology, Medicare Coverage of Innovative Technology (MCIT), Medicare coverage pathway, Reasonable and necessary


Read Full Articlered right arrow icon

News

AAHomecare comments on product innovation

November 3, 2020HME News Staff

WASHINGTON - CMS needs to move away from the gap-fill methodology and develop an alternative payment system, AAHomecare urges in comments to a recent proposed rule on innovation and technology. The association says a new payment system would ensure appropriate payment and access, should a device receive approval under the proposed “Medicare Coverage of Innovative Technology” (MCIT). CMS has proposed MCIT as a streamlined pathway for “FDA-designated breakthrough medical devices”...

AAH, Alternative Payment System, gap-fill methodology, Innovation, Medicare Coverage of Innovative Technology (MCIT), technology


Read Full Articlered right arrow icon